Patents
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
03/2014
03/12/2014CN103635805A Diagnosis of respiratory tract infectious diseases using urine specimens
03/12/2014CN103635188A Methods and compositions using PDE4 inhibitors for the treatment and management of autoimmune and inflammatory diseases
03/12/2014CN103635186A Inhibitors of phosphatidic acid phosphohydrolase (PAP), including D-propranolol and analogs thereof, alone or in combination with desipramine, for the treatment of cancers that depend on the epidermal growth factor receptor (EGFR), oncogenic variants thereof and other members of the ERBB/HER family
03/12/2014CN103626871A Monoclonal antibodies capable of specifically recognizing EGFR mutant protein, preparation method and application thereof
03/12/2014CN103626749A Substituted oxazolidinone compound, and pharmaceutical composition containing compound and application thereof
03/12/2014CN103623416A Targeted ligand-PEG (polyethylene glycol)-cholesterol/tocopherol derivative, and preparation method and application of derivative
03/12/2014CN103623414A Local medicine delivery sustained-release preparation for treating periodontosis
03/12/2014CN103623410A Antibacterial composition, implant material and preparation method of implant material
03/12/2014CN103623409A Antcin derivatives in combination with anti-cancer drugs in the treatment and/or prevention of tumors
03/12/2014CN103623408A Low dose methods for treating disorders in which tnf dollar g(a) activity is detrimental
03/12/2014CN103622920A Nanoparticles containing anti-cancer drugs and preparation method and application thereof
03/12/2014CN103622909A Cardiolipin-containing new liposome preparation, and its application in antitumor drugs
03/12/2014CN103622778A Devices and methods for ophthalmic drug delivery
03/12/2014CN102753159B Pharmaceutical composition comprising propofol
03/12/2014CN102657598B Porous inorganic material based oral preparation of secondary-dispersion insoluble drug and preparation method thereof
03/12/2014CN102389453B Application of traditional Chinese herbal medicine honeysuckle extract for preparing anti-obesity and antihyperlipidemic drugs or drugs with lipase activity inhibitory effect
03/12/2014CN102357142B Use of extract of Chinese herbal medicine seville orange flower in preparation of drug for losing weight and reducing blood fat or drug for inhibiting lipase activity
03/12/2014CN102229650B High purity lipopeptides, lipopeptide micelles and processes for preparing same
03/12/2014CN102143761B Agent for treating myelofibrosis
03/12/2014CN102065854B Combination of pilocarpin and methimazol for treating charcot-marietooth disease and related disorders
03/12/2014CN102026987B Therapeutic agent for pain
03/12/2014CN102018658B Controlled release preparation and preparation method thereof
03/12/2014CN101983193B Prophylactic or therapeutic agent for attention deficit/hyperactivity disorder
03/12/2014CN101884784B Bv8 nucleic acids and polypeptides with mitogenic activity
03/12/2014CN101808627B Antiseptics
03/12/2014CN101217952B Composition for preventing occurrence of cardiovascular event
03/12/2014CN101027061B Pharmaceutical formulations and uses thereof in treatment of female sexual dysfunction
03/11/2014US8668931 Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
03/11/2014CA2396428C Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
03/11/2014CA2375912C Immunotherapy of autoimmune disorders using antibodies which target b-cells
03/06/2014WO2014036555A1 Drug delivery systems and methods for treatment of bladder cancer comprising oxaliplatin
03/06/2014WO2014036391A1 Controls for nucleic acid assays
03/06/2014WO2014036105A2 Inhibitors of memapsin 2 cleavage for the treatment of alzheimer's disease
03/06/2014WO2014035967A2 Antagonists of chemokine receptors
03/06/2014WO2014035846A2 Substituted azaindole compounds, salts, pharmaceutical compositions thereof and methods of use
03/06/2014WO2014035828A2 Inhibition of axl signaling in anti-metastatic therapy
03/06/2014WO2014034890A1 Method for administering hypnotic/sedative agent
03/06/2014WO2014034871A1 Drug for preventing or treating dyslipidemia
03/06/2014WO2014034842A1 Combination of sglt2 inhibitor and anti-hypertension drug
03/06/2014WO2014034798A1 Method for detection of cancer, diagnostic drug and diagnostic kit for cancer, and pharmaceutical composition for treatment of cancer
03/06/2014WO2014034756A1 Pharmaceutical composition for use in treatment of status epilepticus
03/06/2014WO2014034700A1 CELL PROLIFERATION REGULATION COMPOSITION CONTAINING PEPTIDE COMPRISING PARTIAL AMINO ACID SEQUENCE FOR BBF2H7 (BBF2 human homologue on chromosome7) OR ANTIBODY CAPABLE OF BINDING TO SAID PEPTIDE
03/06/2014WO2014034168A1 Evaluation marker for early-stage renal disorder, and method for measuring said evaluation marker
03/06/2014WO2014033463A1 Prevention of the interaction between tenascin-c and mir-155 to treat sepsis
03/06/2014WO2014010654A3 Sulfonamide compound combination
03/06/2014WO2014004902A3 Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof
03/06/2014US20140066623 Ribosome Structure and Protein Synthesis Inhibitors
03/06/2014US20140066513 Methods for compositions for the treatment of irritable bowel syndrome
03/06/2014US20140066494 Acne treatment
03/06/2014US20140066488 Inhibitors of Memapsin 2 Cleavage for the Treatment of Alzheimer's Disease
03/06/2014US20140066487 Antiviral compounds and methods
03/06/2014US20140066476 Modulators of cellular adhesion
03/06/2014US20140066475 Method For Treating Pruritus
03/06/2014US20140066469 Treatment of diseases associated with inflammation
03/06/2014US20140066459 Tetrahydroquinoline derivatives useful as bromodomain inhibitors
03/06/2014US20140066451 Thioxanthene derivatives for the treatment of infectious diseases
03/06/2014US20140066449 Dipyridinium derivatives
03/06/2014US20140066446 2,5-disubstituted arylsulfonamide ccr3 antagonists
03/06/2014US20140066439 Osteoclast activity
03/06/2014US20140066431 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture
03/06/2014US20140066429 Dihydropyridophthalazinone inhibitors of poly(adp-ribose)polymerase (parp) for use in treatment of diseases associated with a pten deficiency
03/06/2014US20140066424 Heterocyclic modulators of hif activity for treatment of disease
03/06/2014US20140066421 Oximes for treatment of peripheral and central nervous system exposure to acetyl cholinesterase inhibitors
03/06/2014US20140066412 Heteroaryl substituted urea modulators of fatty acid amide hydrolase
03/06/2014US20140066399 Pharmacological preparation for topical use containing npalmitoyl-vanillamide
03/06/2014US20140066398 Hcv polymerase inhibitors
03/06/2014US20140066395 Purine nucleoside monophosphate prodrugs for treatment of cancer and viral infections
03/06/2014US20140066369 Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
03/06/2014US20140066367 Subcutaneous delivery of a long-acting natriuretic peptide
03/06/2014US20140066366 Use Of Histones For The Early Diagnosis And/Or Preventive Therapy Of Virally-Infected Living Cells
03/06/2014US20140066362 Method for treating infections by targeting microbial h2s-producing enzymes
03/06/2014US20140065243 Methods and compositions for treating cancer
03/06/2014US20140065241 Uses of (-)-perhexiline
03/06/2014US20140065240 Methods and compositions relating to mesenchymal stem cell exosomes
03/06/2014US20140065231 Controlled release compositions for treatment of cognitive, emotional and mental ailments and disorders
03/06/2014US20140065224 Crystalline n-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations
03/06/2014US20140065218 Novel lactic acid bacteria and compositions containing them against bacterial colds
03/06/2014US20140065214 Delayed-release glucocorticoid treatment of rheumatoid disease
03/06/2014US20140065168 Anti-kit antibodies and uses thereof
03/06/2014US20140065162 Compositions and Methods for Treating Brain Tumors
03/06/2014US20140065161 Treatment method for microbial infection
03/06/2014US20140065160 Combination therapy
03/06/2014US20140065149 Methods for Treating Melanoma
03/06/2014US20140065148 Treatment methods using antibodies to aminophospholipids
03/06/2014US20140065142 Multivalent and Monovalent Multispecific Complexes and Their Uses
03/06/2014US20140065141 Csf-1r inhibitors for treatment of brain tumors
03/06/2014US20140065140 Cancer treatment using viruses and camptothecins
03/06/2014US20140065136 Dioxino- and oxazin-[2,3-d]pyrimidine pi3k inhibitor compounds and methods of use
03/06/2014US20140065135 Methods of using anti-pd-l1 antibodies and their use to enhance t-cell function to treat tumor immunity
03/06/2014US20140065129 Methods and devices for treating parasympathetic bias mediated conditions
03/06/2014US20140065120 Delivery of compounds with rehydrated blood cells
03/06/2014US20140065119 Methods and compositions comprising cyclic analogues of histatin 5 for treating wounds
03/06/2014US20140065102 Methods for the treatment of hepatitis b and hepatitis d infections
03/06/2014US20140065101 2'-Branched Nucleosides for Treatment of Viral Infections
03/06/2014US20140065100 Compositions and Methods for Cancer Immunotherapy
03/06/2014US20140065099 Methods of Treating Mitochondrial Dysfunction
03/06/2014US20140065096 Cancer therapy by ex vivo activated autologous immune cells
03/06/2014US20140065095 Novel inhibitors
03/06/2014US20140065094 Polymer conjugates of box-a of hmgb1 and box-a variants of hmgb1
03/06/2014US20140065063 Therapeutic use of anti-cs1 antibodies
1 ... 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 ... 1151